• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    6.29 Down 0.07(1.10%) 4:00PM EDT
    |After Hours : 6.29 0.00 (0.00%) 4:24PM EDT
    Add to Portfolio
    Prev Close:6.36
    Open:6.36
    Bid:5.89 x 700
    Ask:6.29 x 600
    1y Target Est:12.78
    Beta:2.18
    Earnings Date:Apr 30 - May 4 (Est.)
    Day's Range:6.15 - 6.48
    52wk Range:5.01 - 25.19
    Volume:528,893
    Avg Vol (3m):544,944
    Market Cap:263.47M
    P/E (ttm):48.38
    EPS (ttm):0.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTDown 1.10%263.47M
    NKTRUp 1.98%1.49B
    RHHBYDown 0.12%N/A
    SNSSDown 0.81%165.96M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.18
    Quarterly EPS Est (Mar-15) :-0.24
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback